Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 17.2
(-0.17%)
CNY 17.2
(-0.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 752.55 Million CNY | 0.74% |
| 2022 | 747.05 Million CNY | 15.66% |
| 2021 | 645.89 Million CNY | 118.92% |
| 2020 | 295.03 Million CNY | -4.9% |
| 2019 | 310.22 Million CNY | 37.85% |
| 2018 | 225.05 Million CNY | 106.57% |
| 2017 | 108.94 Million CNY | 48.02% |
| 2016 | 73.6 Million CNY | 15.35% |
| 2015 | 63.81 Million CNY | 8.69% |
| 2014 | 58.7 Million CNY | -23.06% |
| 2013 | 76.3 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 743.59 Million CNY | -12.67% |
| 2024 Q3 | 857.67 Million CNY | 15.34% |
| 2024 Q1 | 851.45 Million CNY | 13.14% |
| 2023 Q1 | 798.46 Million CNY | 6.88% |
| 2023 Q2 | 772.55 Million CNY | -3.24% |
| 2023 Q4 | 752.55 Million CNY | -31.1% |
| 2023 Q3 | 1.09 Billion CNY | 41.38% |
| 2023 FY | 752.55 Million CNY | 0.74% |
| 2022 Q1 | 613.76 Million CNY | -4.97% |
| 2022 Q2 | 628.32 Million CNY | 2.37% |
| 2022 Q3 | 774.73 Million CNY | 23.3% |
| 2022 Q4 | 747.05 Million CNY | -3.57% |
| 2022 FY | 747.05 Million CNY | 15.66% |
| 2021 Q2 | 564.71 Million CNY | 70.08% |
| 2021 Q4 | 645.89 Million CNY | 12.13% |
| 2021 Q3 | 576.05 Million CNY | 2.01% |
| 2021 FY | 645.89 Million CNY | 118.92% |
| 2021 Q1 | 332.02 Million CNY | 12.54% |
| 2020 Q4 | 295.03 Million CNY | 19.49% |
| 2020 Q3 | 246.92 Million CNY | -11.29% |
| 2020 Q1 | 282.88 Million CNY | -8.81% |
| 2020 FY | 295.03 Million CNY | -4.9% |
| 2020 Q2 | 278.35 Million CNY | -1.6% |
| 2019 FY | 310.22 Million CNY | 37.85% |
| 2019 Q3 | 298.24 Million CNY | 27.5% |
| 2019 Q2 | 233.92 Million CNY | 32.43% |
| 2019 Q1 | 176.64 Million CNY | -21.51% |
| 2019 Q4 | 310.22 Million CNY | 4.02% |
| 2018 Q2 | 155.73 Million CNY | 28.98% |
| 2018 Q3 | 157.97 Million CNY | 1.44% |
| 2018 Q4 | 225.05 Million CNY | 42.46% |
| 2018 FY | 225.05 Million CNY | 106.57% |
| 2018 Q1 | 120.74 Million CNY | 10.83% |
| 2017 Q4 | 108.94 Million CNY | 0.45% |
| 2017 FY | 108.94 Million CNY | 48.02% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q3 | 108.45 Million CNY | 51.08% |
| 2017 Q2 | 71.78 Million CNY | 0.0% |
| 2016 Q1 | 72.58 Million CNY | 13.75% |
| 2016 Q3 | - CNY | -100.0% |
| 2016 Q2 | 85.18 Million CNY | 17.36% |
| 2016 Q4 | 73.6 Million CNY | 0.0% |
| 2016 FY | 73.6 Million CNY | 15.35% |
| 2015 Q2 | 49.47 Million CNY | 3.61% |
| 2015 FY | 63.81 Million CNY | 8.69% |
| 2015 Q4 | 63.81 Million CNY | 2.91% |
| 2015 Q3 | 62 Million CNY | 25.34% |
| 2015 Q1 | 47.75 Million CNY | -18.66% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 58.7 Million CNY | 0.19% |
| 2014 Q3 | 58.59 Million CNY | 0.0% |
| 2014 FY | 58.7 Million CNY | -23.06% |
| 2013 FY | 76.3 Million CNY | 0.0% |